| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Sundaram Senthil Vel is a Chief Executive Officer at Terns Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $517K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | TERN Terns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,111 | $1.41 | $2,976.51 | +27.6% | -48.2% | -33.8% | |
| Nov 30, 2022 | TERN Terns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 3 | $1.41 | $4.23 | - | +30.4% | -42.7% | |
| May 31, 2022 | TERN Terns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 7,656 | $1.47 | $11,254.32 | New | +145.7% | +513.3% |